Evoke Pharma, Inc.

Biopharmas large and small will try to make headway into a variety of markets and solidify or expand their foothold in existing markets at this year’s Digestive Disease Week, to be held in Chicago 6-9

The complete response letter from the US Food and Drug Administration announced by Nabriva Therapeutics PLC this week should send chills through the drug development community, standing as one of th

Here's your US review and approval news in brief for the week: Two more novel drugs have cleared the Food and Drug Administration's review hurdle, with Epizyme Inc. 's Tazverik (tazemetostat) and Ho

The US Food and Drug Administration’s growing interest in core clinical outcome assessments is reflected in a revision of a 2015 draft guidance on developing drugs for gastroparesis. The new draft gui